ColonyStimulatingFactor1Receptor(CSF1R,CD115,M-CSF-R)isthereceptorforthecytokineCSF1(MCSF;CSF-1),whichcontrolsthegrowth,function,anddifferentiationofmacrophages.ThisinteractiondrivesthedevelopmentandsurvivalofTumor-AssociatedMacrophages(TAMs),whichinturnsuppressthelocalimmuneresponsetothecancer.AnalternativeligandisIL-34,whichhasbeenimplicatedinneuroprotectiveandsurvivalsignalsfollowingbraininjuryandneurodegeneration.
Asatyrosinekinasetransmembranereceptor,activationofCSF1Rbyitsligandinitiatesavastarrayofintracellularactivity,includingactivationoftheMAPK/ERKsignalingpathway.WhenphosphorylatedbyERK,Elk1formsacomplexwithSerumResponseFactor(SRF)andbindstoSerumResponseElement(SRE),resultingintheexpressionofnumerousmitogen-inducIBLegenes.
TheCSF1RSREReporterKitisdesignedformonitoringtheactivityoftheCSF1Rsignalingpathwayinculturedcells.Thekitcontainsatransfection-readyvectorforCSF1RandSREluciferasereportervector.Uponligandbinding,activeCSF1RwillinitiatetheMAPK/ERKsignalingpathway,leADIngtoexpressionoftheSRE-controlledreporter.ThisreportercontainsthefireflyluciferasegeneunderthecontrolofmultimerizedSREresponsiveelementslocatedupstreamofaminimalpromoter.TheSREreporterispremixedwithaconstitutively-expressingRenillaluciferasevectorthatservesasaninternalcontrolfortransfectionefficiency.
Thekitalsoincludesanon-induciblefireflyluciferasevectorpremixedwithconstitutively-expressingRenillaluciferasevectorasanegativecontrol.Thenon-inducibleluciferasevectorcontainsthefireflyluciferasegeneunderthecontrolofaminimalpromoter,withoutanyadditionalresponseelements.Thenegativecontroliscriticalfordeterminingpathway-specificeffectsandthebackgroundluciferaseactivity.
•Mammaliancelllineandappropriatecellculturemedium
•96-welltissuecultureplateor96-welltissueculture-treatedwhiteclear-bottomassayplate
•Transfectionreagentformammaliancellline[WeuseLipofectamine™2000(Invitrogen#11668027)+Opti-MEMIReducedSerumMedium(Invitrogen#31985-062).However,othertransfectionreagentsworkequallywell.]
•RecombinantHumanCSF1(BPSBioscience,#90215-B)orRecombinantHumanIL34(Biolegend,#577904)
•Lowserum(0.5%FBS)growthmediumoptimizedforparentalcelltype
ForHEK293celllinesuse
BPSMedium8(BPSBioscience,#79385):MEMmedium(Hyclone#SH30024.01)supplementedwith0.5%FBS(Invitrogen#26140-079),1%non-essentialaminoacids(Hyclone#SH30238.01),1mMNapyruvate(Hyclone#SH30239.01),1%Penicillin/Streptomycin(HycloneSV30010.01)
•DualLuciferaseAssaySystem:
DualLuciferase(Firefly-Renilla)AssaySystem(BPSBioscience,#60683):Thissystemassayscellsdirectlyingrowthmedium.Itcanbeusedwithanyluminometer.Automatedinjectorsarenotrequired.
•Luminometer
•MonitorCSF1R/MAPK/ERKsignalingpathwayactivityandSRF-mediatedactivity.
•ScreenforactivatorsorinhibitorsoftheCSF1R/MAPK/ERKsignalingpathway.
•StudyeffectsofRNAiorgeneoverexpression.
1.Cannarile,MichaelA.,etal.“Colony-StimulatingFactor1Receptor(CSF1R)InhibitorsinCancerTherapy.”J.Immunother.Cancer,5(1):53(2017)
2.Liu,Yang,andXuetaoCao.“TheOriginandFunctionofTumor-AssociatedMacrophages.”CellularMolec.Immunology,12(1):1–4(2014).
3.Luo,Jian,etal.“Colony-StimulatingFactor1Receptor(CSF1R)SignalinginInjuredNeuronsFacilitatesProtectionandSurvival.”J.Exp.Med.,210(1):157–172(2013).
4.Yao,G.-Q.,etal.“CSF-1InducesFosGeneTranscriptionandActivatestheTranscriptionFactorElk-1inMatureOsteoclasts.”Calc.TissueInt.,76(5):371–378(2005).
BPS bioscience总部坐落于世界最大之一的美国圣地亚哥生命科学研究机构和公司集中地的中心。公司主要提供激酶、磷酸二酯酶、磷酸酶、组蛋白去甲基化酶、组蛋白甲基化转移酶、HDACs、聚ADP核糖聚合酶。BPS公司为药物研发用重组酶类的提供了最大选择之一。产品类型 重组酶类；分子细胞生物学；重组蛋白；分析试剂盒；底物；重组细胞系
本网站将在规定时间内给予删除等相关处理。
